• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Nakaoku Takashi  中奥 敬史

Researcher Number 20779491
Other IDs
  • ORCIDhttps://orcid.org/0000-0002-6588-8659
Affiliation (Current) 2025: 国立研究開発法人国立がん研究センター, 研究所, ユニット長
Affiliation (based on the past Project Information) *help 2024 – 2025: 国立研究開発法人国立がん研究センター, 研究所, ユニット長
2017 – 2020: 国立研究開発法人国立がん研究センター, 研究所, 研究員
Review Section/Research Field
Principal Investigator
Basic Section 50020:Tumor diagnostics and therapeutics-related / Medium-sized Section 50:Oncology and related fields / Tumor therapeutics
Keywords
Principal Investigator
薬剤耐性 / チロシンキナーゼ阻害剤 / RET / 分子標的治療 / キナーゼ / ゲノム解析 / ゲノム / がんゲノム医療 / キナーゼ阻害剤 / シグナル伝達 … More / 癌 / 肺腺がん / RET融合遺伝子 / 非小細胞肺がん / NF-kB / 非小細胞肺癌 Less
  • Research Projects

    (4 results)
  • Research Products

    (13 results)
  • Co-Researchers

    (2 People)
  •  がん免疫療法に対する応答性決定因子としてのRNAプロセッシング異常の解析Principal Investigator

    • Principal Investigator
      中奥 敬史
    • Project Period (FY)
      2025 – 2027
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      National Cancer Center Japan
  •  Detection of oncodomains using mutation accumulation as an IndicatorPrincipal Investigator

    • Principal Investigator
      中奥 敬史
    • Project Period (FY)
      2024 – 2025
    • Research Category
      Grant-in-Aid for Challenging Research (Exploratory)
    • Review Section
      Medium-sized Section 50:Oncology and related fields
    • Research Institution
      National Cancer Center Japan
  •  Development of RET inhibitor based on the interaction between the kinase protein and inhibitorPrincipal Investigator

    • Principal Investigator
      Nakaoku Takashi
    • Project Period (FY)
      2019 – 2020
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      National Cancer Center Japan
  •  Identification of signaling pathway involving drug resistant in RET-rearranged lung cancerPrincipal Investigator

    • Principal Investigator
      Nakaoku Takashi
    • Project Period (FY)
      2017 – 2018
    • Research Category
      Grant-in-Aid for Young Scientists (B)
    • Research Field
      Tumor therapeutics
    • Research Institution
      National Cancer Center Japan

All 2020 2018 2017

All Journal Article Presentation Book

  • [Book] 遺伝子解析研究の新時代2018

    • Author(s)
      中奥敬史、河野隆志
    • Total Pages
      4
    • Publisher
      医歯薬出版
    • Data Source
      KAKENHI-PROJECT-17K15036
  • [Journal Article] REToma: a cancer subtype with a shared driver oncogene2020

    • Author(s)
      Kohno T, Tabata J, Nakaoku T.
    • Journal Title

      Carcinogenesis

      Volume: in press Issue: 2 Pages: 123-129

    • DOI

      10.1093/carcin/bgz184

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17H04298, KAKENHI-PROJECT-18K19594, KAKENHI-PROJECT-19K16817
  • [Journal Article] A secondary RET mutation in the activation loop conferring resistance to vandetanib.2018

    • Author(s)
      Nakaoku T, Kohno T, Araki M, Niho S, Chauhan R, Knowles PP, Tsuchihara K, Matsumoto S, Shimada Y, Mimaki S, Ishii G, Ichikawa H, Nagatoishi S, Tsumoto K, Okuno Y, Yoh K, McDonald NQ, Goto K
    • Journal Title

      Nature Communications

      Volume: 9 Issue: 1 Pages: 625-625

    • DOI

      10.1038/s41467-018-02994-7

    • NAID

      120006406830

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K15036, KAKENHI-PROJECT-16H02420
  • [Presentation] Targeting RET-VUS in precision oncology using molecular dynamics simulation2020

    • Author(s)
      Takashi Nakaoku, Junya Tabata, Mitsugu Araki, Yasushi Okuno, Takashi Kohno
    • Organizer
      第79回 日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-19K16817
  • [Presentation] Druggable oncogene fusions and resistance mechanisms in lung cancer2018

    • Author(s)
      Takashi Nakaoku, Mitsugu Araki, Seiji Niho, Rakhee Chauhan, Phillip P. Knowles, Katsuya Tsuchihara6, Shingo Matsumoto, Yoko Shimada, Sachiyo Mimaki, Genichiro Ishii, Hitoshi Ichikawa, Yasushi Okuno, Kiyotaka Yoh, Neil Q. McDonald, Koichi Goto, Takashi Kohno
    • Organizer
      The 6th JCA-AACR Special Joint Conference
    • Invited / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K15036
  • [Presentation] A secondary RET mutation allosterically conferring resistance to vandetanib2018

    • Author(s)
      Takashi Nakaoku, Takashi Kohno, Mitsugu Araki, Seiji Niho, Rakhee Chauhan, Phillip P. Knowles, Katsuya Tsuchihara, Shingo Matsumoto, Yoko Shimada, Sachiyo Mimaki, Genichiro Ishii, Hitoshi Ichikawa, Yasushi Okuno, Kiyotaka Yoh, Neil Q. McDonald, Koichi Goto
    • Organizer
      AACR annual meeting 2018
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K15036
  • [Presentation] Molecular targeted therapy for lung cancer based on driver oncogenes such as RET and NRG1 fusions2018

    • Author(s)
      Takashi Nakaoku, Takashi Kohno
    • Organizer
      第77回日本癌学会学術総会
    • Invited
    • Data Source
      KAKENHI-PROJECT-17K15036
  • [Presentation] RET S904F変異によるアロステリック効果を介したバンデタニブ耐性機構2018

    • Author(s)
      中奥 敬史、仁保 誠治、土原 一哉、 松本 慎吾、市川 仁、葉 清隆、後藤功一、河野 隆志
    • Organizer
      第59回日本肺癌学会学術集会
    • Data Source
      KAKENHI-PROJECT-17K15036
  • [Presentation] A Secondary RET Mutation in the Activation Loop Conferring Resistance to Vandetanib Through Allosteric Effects2018

    • Author(s)
      Takashi Nakaoku, Mitsugu Araki, Seiji Niho, Rakhee Chauhan, Phillip P. Knowles, Katsuya Tsuchihara, Shingo Matsumoto, Yoko Shimada, Sachiyo Mimaki, Genichiro Ishii, Hitoshi Ichikawa, Satoru Nagatoishi, Kouhei Tsumoto, Yasushi Okuno, Kiyotaka Yoh, Neil Q. McDonald, Koichi Goto, Takashi Kohno
    • Organizer
      Cambridge Healthtech Institute's 2018 Drug Discovery Chemistry conference
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K15036
  • [Presentation] Identification of mechanisms of drug resistance in RET-rearranged lung cancer2017

    • Author(s)
      Takashi Nakaoku, Takashi Kohno
    • Organizer
      18th World Conference on Lung Cancer
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K15036
  • [Presentation] RET融合遺伝子陽性肺がんにおける薬剤耐性メカニズムの解明2017

    • Author(s)
      中奥 敬史、河野 隆志
    • Organizer
      第58回日本肺癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K15036
  • [Presentation] RET融合遺伝子陽性肺がんにおける薬剤耐性メカニズムの解明2017

    • Author(s)
      中奥 敬史、大塚 綾香、河野 隆志
    • Organizer
      第76回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K15036
  • [Presentation] 6.RET融合遺伝子陽性肺がんにおける薬剤耐性メカニズムの解明2017

    • Author(s)
      中奥 敬史、河野 隆志
    • Organizer
      金沢大学がん進展制御研究所 共同利用・共同研究拠点シンポジウム
    • Data Source
      KAKENHI-PROJECT-17K15036
  • 1.  吉野 龍ノ介 (50817575)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 2.  河野 隆志
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results

URL: 

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi